These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 15928974
1. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Fraga M, Scavone P, Zunino P. Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974 [Abstract] [Full Text] [Related]
2. Defined mutants of Proteus mirabilis lacking flagella cause ascending urinary tract infection in mice. Legnani-Fajardo C, Zunino P, Piccini C, Allen A, Maskell D. Microb Pathog; 1996 Nov; 21(5):395-405. PubMed ID: 8938645 [Abstract] [Full Text] [Related]
3. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Zunino P, Piccini C, Legnani-Fajardo C. Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921 [Abstract] [Full Text] [Related]
5. Evaluation of inhibitory activity of domestic probiotics for against invasion and infection by Proteus mirabilis in the urinary tract. Lai TM, Lin PP, Hsieh YM, Tsai CC. J Infect Dev Ctries; 2020 Apr 30; 14(4):366-372. PubMed ID: 32379713 [Abstract] [Full Text] [Related]
7. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract. Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P. Pathog Dis; 2013 Mar 30; 67(2):104-7. PubMed ID: 23620155 [Abstract] [Full Text] [Related]
11. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Alamuri P, Mobley HL. Mol Microbiol; 2008 May 30; 68(4):997-1017. PubMed ID: 18430084 [Abstract] [Full Text] [Related]
12. Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis. Satoh M, Munakata K, Takeuchi H, Yoshida O. Hinyokika Kiyo; 1994 Aug 30; 40(8):689-94. PubMed ID: 7942366 [Abstract] [Full Text] [Related]
18. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. Pearson MM, Mobley HLT. J Med Microbiol; 2007 Oct 15; 56(Pt 10):1277-1283. PubMed ID: 17893161 [Abstract] [Full Text] [Related]
19. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Scavone P, Miyoshi A, Rial A, Chabalgoity A, Langella P, Azevedo V, Zunino P. Microbes Infect; 2007 Jun 15; 9(7):821-8. PubMed ID: 17540603 [Abstract] [Full Text] [Related]
20. [Examination of selected biological properties for swarm cells in Proteus mirabilis]. Krajewska-Pietrasik D, Rózalski A, Zych K, Gromska W, Chomiczewski K, Kotełko K. Med Dosw Mikrobiol; 1998 Jun 15; 50(1-2):21-9. PubMed ID: 9857610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]